9 Aug 2011 12:40
e-Therapeutics plc (the "Company")
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
The Company was informed today that Prof Malcolm Young, Chief Executive has transferred today 10,310,241 ordinary shares to his wife for routine tax planning purposes. Prof Young's resultant direct holding remains unchanged at 20,620,482 shares representing 14.93% of the total voting rights of the Company.
Prof Young also has an indirect holding of a further 428,512 shares due to interests that he holds in Novotech Investments Ltd and Novotech Syndicate LLP. There has been no change to this interest.
9 August 2011
Contacts
e-Therapeutics plc Tel: +44 (0) 191 233 1317
Prof Malcolm Young
Panmure Gordon (UK) Limited Tel: +44 (0)20 7459 3600
Aubrey Powell / Andrew Burnett
ETX.L (ETX)